Cannabinoids for pain or profit?

Rae F Bell¹, Eija A Kalso^{2

3

4}

Affiliations

¹ Regional Centre of Excellence in Palliative Care, Haukeland University Hospital, Bergen, Norway.
² Faculty of Medicine, University of Helsinki, Helsinki, Finland.
³ Department of Pharmacology and SleepWell Research Programme, University of Helsinki, Helsinki, Finland.
⁴ Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital, Helsinki, Finland.

Comment

Rae F Bell et al. Pain. 2021.

. 2021 Jul 1;162(Suppl 1):S125-S126.

doi: 10.1097/j.pain.0000000000001930.

Rae F Bell¹, Eija A Kalso^{2

3

4}

¹ Regional Centre of Excellence in Palliative Care, Haukeland University Hospital, Bergen, Norway.
² Faculty of Medicine, University of Helsinki, Helsinki, Finland.
³ Department of Pharmacology and SleepWell Research Programme, University of Helsinki, Helsinki, Finland.
⁴ Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital, Helsinki, Finland.

No abstract available

Comment on

Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.
Fisher E, Moore RA, Fogarty AE, Finn DP, Finnerup NB, Gilron I, Haroutounian S, Krane E, Rice ASC, Rowbotham M, Wallace M, Eccleston C. Fisher E, et al. Pain. 2021 Jul 1;162(Suppl 1):S45-S66. doi: 10.1097/j.pain.0000000000001929. Pain. 2021. PMID: 32804836

1. Boland EG, Bennett MI, Allgar V, Boland JW. Cannabinoids for adult cancer-related pain: systematic review and meta-analysis. BMJ Support Palliat Care 2020;10:14–24.
1. Buxbaum DM. Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse. Psychopharmacologia 1972;25:275–80.
1. Chesher GB, Dahl CJ, Everingham M, Jackson DM, Marchant-Williams H, Starmer GA. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br J Pharmacol 1973;49:588–94.
1. Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007:CD004959.
1. European Monitoring Centre for Drugs and Drug addiction: Medical use of cannabis and cannabinoids. Questions and answers for policymaking. December 2018. Available at: www.emcdda.europa.eu . Accessed May 10, 2020.